FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:1305-1307 April 30, 1998 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Gleave, M. E. Related Article by Negrier, S. PubMed Citation

Renal-cell carcinoma constitutes about 2 percent of all cancers, and its incidence is steadily rising. The sporadic form of the disease usually presents in the fifth, sixth, or seventh decade of life, often with locally advanced tumors that are diagnosed after patients notice hematuria or flank pain or present with an abdominal mass. These tumors are twice as common in men as in women, and most arise from the renal cortex. The uncommon familial forms of the disease, seen in disorders such as von Hippel–Lindau disease and tuberous sclerosis, are associated with t(3;8), t(3;6), and t(3;11) translocations.¹

Surgery remains the . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Coutinho, E. L., de Sousa Andrade, L. N., Chammas, R., Morganti, L., Schor, N., Bellini, M. H. (2007). Anti-tumor effect of endostatin mediated by retroviral gene transfer in mice bearing renal cell carcinoma. FASEB J. 21: 3153-3161 [Abstract] [Full Text]  
• Miyajima, A., Kosaka, T., Asano, T., Asano, T., Seta, K., Kawai, T., Hayakawa, M. (2002). Angiotensin II Type I Antagonist Prevents Pulmonary Metastasis of Murine Renal Cancer by Inhibiting Tumor Angiogenesis. Cancer Res. 62: 4176-4179 [Abstract] [Full Text]  
• Knoll, K., Wrasidlo, W., Scherberich, J. E., Gaedicke, G., Fischer, P. (2000). Targeted Therapy of Experimental Renal Cell Carcinoma with a Novel Conjugate of Monoclonal Antibody 138H11 and Calicheamicin {{theta}}I1. Cancer Res. 60: 6089-6094 [Abstract] [Full Text]  
• Galanis, E., Hersh, E. M., Stopeck, A. T., Gonzalez, R., Burch, P., Spier, C., Akporiaye, E. T., Rinehart, J. J., Edmonson, J., Sobol, R. E., Forscher, C., Sondak, V. K., Lewis, B. D., Unger, E. C., O'Driscoll, M., Selk, L., Rubin, J. (1999). Immunotherapy of Advanced Malignancy by Direct Gene Transfer of an Interleukin-2 DNA/DMRIE/DOPE Lipid Complex: Phase I/II Experience. JCO 17: 3313-3323 [Abstract] [Full Text]  
• Kemp, C. (1999). Part three: Kidney cancer, leukemia, and liver cancer. AM J HOSP PALLIAT CARE 16: 479-486 [Abstract]